Is CCDC136 p.Glu225Val (c.674A>T) pathogenic?

CCDC136 p.Glu225Val (c.674A>T) is classified Uncertain significance in CCDC136 (ClinVar, Single submitter, 1 submitter; last evaluated 2025-10-30). AlphaMissense: likely pathogenic (0.672); Very rare (popmax 0.00708%, nfe).

How common is CCDC136 p.Glu225Val (c.674A>T) in the general population?

CCDC136 p.Glu225Val (c.674A>T) is very rare (popmax 0.00708%, nfe) (gnomAD).

What do computational predictors say about CCDC136 p.Glu225Val (c.674A>T)?

AlphaMissense predicts likely pathogenic (score 0.672) — an in-silico prediction, not a clinical call.

CCDC136 p.Glu225Val

c.674A>T · VCV4649017

Uncertain significance Single submitter

Classification

Uncertain significance

ClinVar

Review

Single submitter ★☆☆☆

ClinVar · 1 submitter

AlphaMissense

likely pathogenic

0.672 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.00708%, nfe)

Missense predictors

2/2 damaging

AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense	0.672	likely pathogenic
REVEL	0.468	indeterminate
SaProt	LLR -11.57	damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI	Δ0.30	acceptor loss at this position · masked 0 · deltas
Constraint at this position
Conservation	phyloP 11	phastCons 1
Regional constraint	o/e 0.87	unconstrained · MANE · 25 kb · p 3e-06 · regional, not allelic
Overall
CADD	26.2	PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00708% European (non-Finnish) · 81/1,143,340 alleles

Filtering AF 0.00581% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00531%

Overall 0.00541% 84/1,552,756 alleles · very rare

Ancestry group	Frequency	1 in
European (non-Finnish)grpmax	0.00708%	14,115
Admixed American	0.00191%	52,414
Remaining individualsnot grpmax-eligible	0.00166%	60,354
Finnishnot grpmax-eligible	0.00164%	60,922

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: CCDC136
Protein: p.Glu225Val
Coding: c.674A>T
MANE Select: NM_022742
Type: single nucleotide variant
Location: chr7:128804653 (GRCh38)
Gene constraint: LOEUF 0.924 · pLI <0.01 (gnomAD)
Structure: AlphaFold pLDDT 69.24

Full CCDC136 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

CCDC136 p.Ala687= Benign ★★ same type
CCDC136 p.Asp218His Benign ★★ ⚠ same type
CCDC136 p.Glu1087= Benign ★★ same type
CCDC136 p.Glu1097Gly Likely benign ★★ ⚠ same type
CCDC136 p.Gly221= Benign ★★ same type
CCDC136 p.Gly980Arg Benign ★★ same type
CCDC136 p.Leu616= Benign ★★ same type
CCDC136 p.Val432Ile Benign ★★ same type

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ccdc136-p-glu225val (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown